| Christopher Robert Chuinard, MD | |
|
4045 W Royal Dr, Traverse City, MI 49684-8965 | |
| (231) 935-0900 | |
| (231) 935-0308 |
| Full Name | Christopher Robert Chuinard |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 4045 W Royal Dr, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205926268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4301088953 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Otsego Memorial Hospital | Gaylord, MI | Hospital |
| Charlevoix Area Hospital | Charlevoix, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Great Lakes Orthopaedic Center Pc | 1759371826 | 28 |
News Archive
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany). The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific's magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany). The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific's magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.
› Verified 1 days ago
| Entity Name | Great Lakes Orthopaedic Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952323453 PECOS PAC ID: 1759371826 Enrollment ID: O20040512001442 |
News Archive
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany). The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific's magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.
› Verified 1 days ago
| Entity Name | Kalkaska Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013183060 PECOS PAC ID: 3577536002 Enrollment ID: O20040813000668 |
News Archive
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany). The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific's magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Robert Chuinard, MD 4045 W Royal Dr, Traverse City, MI 49684-8965 Ph: (231) 935-0900 | Christopher Robert Chuinard, MD 4045 W Royal Dr, Traverse City, MI 49684-8965 Ph: (231) 935-0900 |
News Archive
Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany). The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific's magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.
› Verified 1 days ago
Dr. Justin Joseph Hollander, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5246 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0957 Fax: 231-935-0960 | |
Thomas Freeman Jr., MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4045 W Royal Dr, Traverse City, MI 49684 Phone: 231-935-0900 Fax: 833-471-4024 | |
Dr. Thomas V O'hagan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4045 W Royal Dr, Traverse City, MI 49684 Phone: 231-935-0900 | |
Dr. John Robert Reineck, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4045 W Royal Dr, Traverse City, MI 49684 Phone: 231-935-0900 Fax: 231-935-0308 | |
Dr. Joseph M Mcgraw, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4045 W Royal Dr, Traverse City, MI 49684 Phone: 231-935-0900 Fax: 231-935-0308 | |
Dr. Eric Lerche, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5246 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0957 |